Your browser is no longer supported. Please, upgrade your browser.
NRx Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-7.60 Insider Own1.30% Shs Outstand41.73M Perf Week17.48%
Market Cap692.24M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float18.83M Perf Month6.33%
Income-298.50M PEG- EPS next Q- Inst Own4.00% Short Float9.03% Perf Quarter-32.58%
Sales- P/S- EPS this Y-596.10% Inst Trans-0.04% Short Ratio0.31 Perf Half Y-66.35%
Book/sh-0.42 P/B- EPS next Y- ROA- Target Price- Perf Year4.03%
Cash/sh0.21 P/C51.66 EPS next 5Y- ROE- 52W Range6.43 - 76.99 Perf YTD-54.55%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-85.60% Beta0.31
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin- 52W Low72.59% ATR1.38
Employees2 Current Ratio0.50 Sales Q/Q- Oper. Margin- RSI (14)53.15 Volatility12.92% 12.96%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.26 Prev Close11.09
ShortableYes LT Debt/Eq- EarningsAug 16 AMC Payout- Avg Volume5.42M Price11.09
Recom- SMA2017.29% SMA50-4.98% SMA200-53.66% Volume0 Change0.00%
Oct-14-21 06:48AM  
Oct-12-21 06:48AM  
Sep-29-21 06:48AM  
Sep-27-21 07:04AM  
Sep-08-21 07:48AM  
Aug-30-21 08:06AM  
Aug-26-21 06:48AM  
Aug-25-21 09:43AM  
Aug-24-21 06:48AM  
Aug-23-21 09:33AM  
Aug-19-21 09:17AM  
Aug-18-21 11:53AM  
Aug-16-21 09:32PM  
Aug-11-21 04:20PM  
Aug-10-21 06:48AM  
Aug-09-21 01:13PM  
Aug-04-21 06:48AM  
Jul-27-21 11:34AM  
Jul-22-21 06:48AM  
Jul-19-21 06:48AM  
Jul-12-21 11:18AM  
Jul-06-21 09:20AM  
Jun-15-21 07:33AM  
Jun-09-21 02:50PM  
Jun-08-21 02:03PM  
Jun-07-21 01:45PM  
Jun-01-21 06:28AM  
May-27-21 06:48AM  
May-26-21 09:29AM  
NRx Pharmaceuticals, Inc. a clinical-stage, small molecule pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.